Adalimumab for the treatment of severe psoriasis and psoriatic arthritis

Author： Papoutsaki Marina   Costanzo Antonio   Chimenti Maria-Sole   Chimenti Sergio  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.8, Iss.3, 2008-03, pp. : 363-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis

By Saraceno Rosita  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1325-1334

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis

By Mease Philip J  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 11, 2005-11 ,pp. : 1491-1504

Informa Healthcare

Access to resources Recommend Favorite

Psoriasis and its treatment with adalimumab

By Iaconi Ala   Feldman Steven R   Balkrishnan Rajesh  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 1, 2010-01 ,pp. : 133-152

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab in the treatment of rheumatoid arthritis

By Voulgari Paraskevi V   Kaltsonoudis Evripidis   Papagoras Charalampos   Drosos Alexandros A  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1679-1686

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF-α agents in the treatment of psoriatic arthritis

By Brandt Jan   Braun Jürgen  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 2, 2006-02 ,pp. : 99-107

Informa Healthcare

Access to resources Recommend Favorite